Sign up for FlowVella
Sign up with FacebookAlready have an account? Sign in now
By registering you are agreeing to our
Terms of Service
Loading Flow
- Options for second-line treatment include pemetrexed, docetaxel and erlotinib.
- Erlotinib has been approved by NICE as second-line treatment as an alternative to docetaxel.
Based on NICE 2012
Continue pharmacotherapy of NSCLC